Chris joined Arlington in 2011 and focuses on investing in the aerospace, defense, healthcare, software and IT services sectors. Prior to joining Arlington, Chris worked for Deutsche Bank’s Financial Sponsors Group in New York. While at Deutsche Bank, Chris worked on numerous transactions for the bank’s financial sponsor clients including leveraged buyouts, refinancings, mergers and acquisitions and equity offerings.
Chris graduated summa cum laude with honors from the University of Georgia’s Terry College of Business where he received a B.B.A. in both Finance and Real Estate.
Chris currently serves on the Board of Directors of Endeavor Robotics, Molecular Products and Zemax. Chris works actively on the firm’s investment in Quantum Spatial. Chris previously worked on the firm’s prior investments in Cambridge Major Laboratories, MB Aerospace and Micron Technologies.